Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003287

Options or other derivatives

  • President and CEO acquired 315,316 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Blume-Jensen Peter · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +225,226 225,226 D
2024-03-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +90,090 90,090 I
Loading xslF345X05/form4.xml…